IQ-AI Ltd

  • News & Announcements
  • Shareholder Information
  • Investor Relations
  • Significant Shareholders
  • Publications
  • Home
  • Corporate News & Announcements
  • IQ-AI RNS News & Announcements
  • Keck Medical Centre of USC Purchases IB’s Software
 

News

Wednesday, 16 September 2020 / Published in IQ-AI RNS News & Announcements

Keck Medical Centre of USC Purchases IB’s Software

RNS Number : 0876Z
IQ-AI Limited
16 September 2020
 

IQ-AI Ltd

(“IQ-AI” or the “Company”)

Keck Medical Center of USC Purchases Imaging Biometrics’ Software

Imaging Biometrics®, LLC (“IB”), a subsidiary of IQ-AI Limited (LON:IQAI), is pleased to announce that the Keck Medical Center of USC has purchased IB Clinic for automatically generating IB’s quantitative parameter maps. The installation provides Keck Medical Center with a processing solution that allows for standardised brain tumour imaging across multiple sites and platforms for its patients.

IB clinic includes the IB Neuro™ module, which generates images of relative cerebral blood volume (rCBV), a magnetic resonance imaging (MRI) method for evaluating brain tumours. As many studies have shown, higher rCBV is correlated with more aggressive tumours (higher tumour grade) and provides information for diagnosis and treatment optimisation. IB Neuro’s capabilities from its inception are consistent with national consensus recommendations for collecting and processing rCBV data as published in Neuro-Oncology.

Unique to IB Neuro is the ability to automatically account for variability inherent with MRI systems by translating the relative MR intensity values to a fixed and consistent scale regardless of scanner platform, field strength, patient, or time point. Quantitatively assessing how a tumour is changing over time is critical for both clinicians and their patients.

“The reliability of IB Neuro’s rCBV maps empower our physicians with confidence that we are making the right decisions for our patients,” says Mark Shiroishi, MD, Director of Neuro-Oncology Imaging at Keck Medical Center and Chief of Pediatric Neuroradiology at the LA County/USC Medical Center.

IB Clinic’s imaging suite at Keck Medical Center includes automated Delta T1™ maps, quantitative subtraction maps proven to eliminate confounding artifacts, such as blood products, and enable objective and rapid identification of true contrast enhancing regions for radiologists. The two biomarkers, IB’s Delta T1 and rCBV maps, provide complementary information that aids the diagnostic process and improves productivity.

“We are excited that Keck Medical Center has adopted our brain tumour imaging platform. IB Clinic’s quantitative output is ideal for major cancer centers such as Keck Medical Center as it automates and standardises care across sites, scanners, and patients. We are equally excited for the collaborative research relationships now established between our two organisations and translating future developments that may result,” said Michael Schmainda, CEO of IB.

The Directors of the Company accept responsibility for the contents of this announcement.

 

-ENDS-

For further information, please contact:

IQ-AI Limited

Trevor Brown/Vinod Kaushal/Qu Li

Tel: 020 7469 0930

Peterhouse Capital Limited (Financial Adviser and Broker)

Lucy Williams/Heena Karani

Tel: 020 7220 9797

 

About Keck Medicine of USC

Keck Medicine of USC is the University of Southern California’s medical enterprise, one of only two university-based medical systems in the Los Angeles area. Keck Medicine combines academic excellence, world-class research and state-of-the-art facilities to provide highly specialized care for some of the most acute patients in the country.  

Its internationally renowned physicians and scientists provide world-class patient care at Keck Hospital of USC, USC Norris Cancer Hospital, USC Verdugo Hills Hospital and more than 80 outpatient locations in Los Angeles, Orange, Kern, Tulare and Ventura counties. 

Keck Medical Center of USC was ranked among the top 20 hospitals nationwide on U.S. News & World Report’s 2020-21 Best Hospitals Honor Roll and among the top 3 hospitals in Los Angeles and top 5 in California.

About Imaging Biometrics, LLC

Imaging Biometrics®, a subsidiary of IQ-AI Limited (LON:IQAI), develops and provides visualisation and analytical solutions that enable clinicians to better diagnose and treat disease with greater confidence. Through close collaboration with top researchers and clinicians, sophisticated advancements are translated into platform-independent and automated software plug-ins which can extend the base functionality of workstations, imaging systems, PACS, or medical viewers. By design, IB’s advanced visualisation software seamlessly integrates into routine workflows. For more information about Imaging Biometrics, visit the company’s website at www.imagingbiometrics.com.

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
Article source

Recent Posts

  • Notice of AGM

    RNS Number : 4440K IQ-AI Limited 05 May 2022   ...
  • IB Broadens Quantitative Mapping

    RNS Number : 1476K IQ-AI Limited 03 May 2022   ...
  • IB Broadens Quantitative Mapping

    – Article source...
  • Final Results

    RNS Number : 7683J IQ-AI Limited 28 April 2022 ...
  • IQAI’s Sponsored Phase I Clinical Trial is Open

    RNS Number : 2319E IQ-AI Limited 09 March 2022 ...
Portions copyright © 2010-2022 IQ-AI Ltd. All Rights Reserved.
TOP
Our website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.AcceptReject
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT